Thursday, August 14, 2014 11:49:02 PM
Yes, I agree 100% with the expected profitability for the upcoming quarters for GRCU... starting with profitability transpiring the next quarter. Their huge Profit Margin that was indicated sets the stage for what’s to be expected with the growth of GRCU as we can derive the Profit Margin as below from these recent financials:
http://www.otcmarkets.com/financialReportViewer?symbol=GRCU&id=125012
Revenue = $19,779
Cost of Sales = $7,813
Gross Profit = $11,966
$11,966 Gross Profit ÷ $19,779 Revenues = 60.5% Gross Profit Margin
Now to consider this 60.5% Gross Profit Margin and a sellout of ”just one” of their CBD oil products in just a matter of a couple of weeks or so, we should be expecting some significant numbers next quarter to include expecting ”exponential growth” for the succeeding quarters. Now consider that GRCU plans to introduce, both under its own brands and labels currently under exclusive licensing, a minimum of 30 potential nutritional and medicinal cannabis derived products by the end of 4th quarter of 2014 as stated in an earlier GRCU PR. Now add the expected international sales.
Now throw in any kind of cultivation revenues generated from its previous mention too, then I think investors will begin to understand the potential that's being manifested here with GRCU.
Before talking further about the $35,541,443 listed on the Balance Sheet as the "Accumulated Deficit" within the GRCU financials, I think it is important to read and understand Page 5 under the section titled Financials Statements:
For inquiring minds, this coincides with the thoughts within an earlier post that I made below:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104702356
These posts below courtesy of the posters Positivevibes, Odessa99, philipt631, RoboTrader, rick85, and THE GOLD STANDARD sums it up pretty good:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105320363
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105320529
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105321177
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105321166
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105320918
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105321058
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105320871
After reading the links above, much would be understood. Since the $35,541,443 was before Feb 25, 2014, this means that it is not applicable to be a GRCU liability. The $35,541,443 doesn't represent a liability. It represents the sum total of the losses of prior years (before green cures came into existence) and is known as an accumulated deficit. The current quarter's Balance Sheet reflects that the total liabilities for the company is just $110,305. This is the total amount that GRCU now actually owes based upon the current company operations. This is awesome!
They will be able to use the negative $35,541,443 listed on the Balance Sheet as the "Accumulated Deficit" as a Net Operating Loss (NOL) Carry Forward. They will be able to preserve this $35.5 Million NOL Carry Forward for the next 2 to 10 years. The company will have the option to either apply the NOL of its past tax payments and receive a tax credit or they could apply the NOL to future income tax payments to reduce their need to make payments for future periods. Given the expected future revenues, I suspect the latter. See below for a little better detailed explanation for the Net Operating Loss (NOL):
I too believe as you in that their financials were done well and were done in a way that is very easy to read. I thought they were prepared very well and proved to be well worth the weight. The financials confirm how the company has positioned itself to be greatly profitable.
It looks like GRCU is on track to generate profits based on the Robert Calkin model indicated below:
v/r
Sterling
Sterling's Trading & Investing Strategies:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39092516
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM